nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRB—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0308	0.165	CbGpPWpGaD
Isotretinoin—RXRA—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.016	0.0862	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00611	0.0328	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00548	0.0294	CbGpPWpGaD
Isotretinoin—RARB—respiratory system—chronic obstructive pulmonary disease	0.00528	0.19	CbGeAlD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00525	0.0282	CbGpPWpGaD
Isotretinoin—Alitretinoin—CYP1A2—chronic obstructive pulmonary disease	0.0044	0.324	CrCbGaD
Isotretinoin—RARB—bronchus—chronic obstructive pulmonary disease	0.00435	0.156	CbGeAlD
Isotretinoin—RARG—respiratory system—chronic obstructive pulmonary disease	0.00431	0.155	CbGeAlD
Isotretinoin—RARA—respiratory system—chronic obstructive pulmonary disease	0.00405	0.146	CbGeAlD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00394	0.0212	CbGpPWpGaD
Isotretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—chronic obstructive pulmonary disease	0.00337	0.0181	CbGpPWpGaD
Isotretinoin—Vitamin A—CYP1A1—chronic obstructive pulmonary disease	0.00333	0.245	CrCbGaD
Isotretinoin—Tretinoin—CYP1A1—chronic obstructive pulmonary disease	0.00322	0.237	CrCbGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00315	0.0169	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00312	0.0168	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00299	0.0161	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00296	0.0159	CbGpPWpGaD
Isotretinoin—RARB—lung—chronic obstructive pulmonary disease	0.00281	0.101	CbGeAlD
Isotretinoin—Acitretin—ALB—chronic obstructive pulmonary disease	0.00265	0.195	CrCbGaD
Isotretinoin—RXRB—lung—chronic obstructive pulmonary disease	0.00258	0.0927	CbGeAlD
Isotretinoin—RXRA—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00247	0.0133	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.00244	0.0131	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00236	0.0127	CbGpPWpGaD
Isotretinoin—RARG—lung—chronic obstructive pulmonary disease	0.00229	0.0823	CbGeAlD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00221	0.0119	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00216	0.0116	CbGpPWpGaD
Isotretinoin—RARA—lung—chronic obstructive pulmonary disease	0.00215	0.0774	CbGeAlD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00212	0.0114	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00203	0.0109	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00203	0.0109	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00202	0.0109	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00198	0.0106	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00194	0.0104	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.0019	0.0102	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.0019	0.0102	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00182	0.0098	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00174	0.00934	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00156	0.00837	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00156	0.00837	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00154	0.00828	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic obstructive pulmonary disease	0.00144	0.00776	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00141	0.00757	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00137	0.00735	CbGpPWpGaD
Isotretinoin—RXRA—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00129	0.00694	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00129	0.00691	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.00127	0.0068	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00126	0.00678	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.0012	0.00647	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00116	0.00624	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00115	0.00616	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00114	0.00611	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00113	0.00609	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.00113	0.00608	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00111	0.00596	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00106	0.00569	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00102	0.0055	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00102	0.00549	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00101	0.00545	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.000989	0.00532	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000962	0.00517	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00095	0.00511	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000945	0.00508	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000943	0.00507	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000922	0.00495	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000912	0.0049	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0009	0.00484	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.000897	0.00482	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00089	0.00478	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000889	0.00478	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000828	0.00445	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000783	0.00421	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000777	0.00418	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000761	0.00409	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000757	0.00407	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000748	0.00402	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000742	0.00399	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000712	0.00383	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000712	0.00383	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000711	0.00382	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000702	0.00377	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00067	0.0036	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000654	0.00351	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000633	0.0034	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000624	0.00335	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000597	0.00321	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00059	0.00317	CbGpPWpGaD
Isotretinoin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000586	0.000759	CcSEcCtD
Isotretinoin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000585	0.000758	CcSEcCtD
Isotretinoin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.000758	CcSEcCtD
Isotretinoin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000583	0.000755	CcSEcCtD
Isotretinoin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.000751	CcSEcCtD
Isotretinoin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000579	0.000749	CcSEcCtD
Isotretinoin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000578	0.000748	CcSEcCtD
Isotretinoin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.000748	CcSEcCtD
Isotretinoin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000577	0.000747	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000573	0.00308	CbGpPWpGaD
Isotretinoin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000573	0.000742	CcSEcCtD
Isotretinoin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000739	CcSEcCtD
Isotretinoin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.000736	CcSEcCtD
Isotretinoin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.000736	CcSEcCtD
Isotretinoin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.000732	CcSEcCtD
Isotretinoin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000563	0.000729	CcSEcCtD
Isotretinoin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000563	0.000729	CcSEcCtD
Isotretinoin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000563	0.000728	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000561	0.00302	CbGpPWpGaD
Isotretinoin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.000725	CcSEcCtD
Isotretinoin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.000725	CcSEcCtD
Isotretinoin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.000724	CcSEcCtD
Isotretinoin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.000722	CcSEcCtD
Isotretinoin—RXRG—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000557	0.00299	CbGpPWpGaD
Isotretinoin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.000719	CcSEcCtD
Isotretinoin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000555	0.000718	CcSEcCtD
Isotretinoin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.000715	CcSEcCtD
Isotretinoin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.000712	CcSEcCtD
Isotretinoin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.000712	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.000711	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000549	0.000711	CcSEcCtD
Isotretinoin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000545	0.000705	CcSEcCtD
Isotretinoin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.000705	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000544	0.00292	CbGpPWpGaD
Isotretinoin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.000702	CcSEcCtD
Isotretinoin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.000701	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000538	0.000696	CcSEcCtD
Isotretinoin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.000695	CcSEcCtD
Isotretinoin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000537	0.000695	CcSEcCtD
Isotretinoin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.000693	CcSEcCtD
Isotretinoin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000536	0.000693	CcSEcCtD
Isotretinoin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000534	0.000691	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000689	CcSEcCtD
Isotretinoin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.000688	CcSEcCtD
Isotretinoin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00053	0.000687	CcSEcCtD
Isotretinoin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.000687	CcSEcCtD
Isotretinoin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00053	0.000686	CcSEcCtD
Isotretinoin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.000684	CcSEcCtD
Isotretinoin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000525	0.000679	CcSEcCtD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000524	0.00282	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000524	0.00282	CbGpPWpGaD
Isotretinoin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.000678	CcSEcCtD
Isotretinoin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000522	0.000676	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00052	0.000673	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.000673	CcSEcCtD
Isotretinoin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000519	0.000672	CcSEcCtD
Isotretinoin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.000672	CcSEcCtD
Isotretinoin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000519	0.000672	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.000671	CcSEcCtD
Isotretinoin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.000667	CcSEcCtD
Isotretinoin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000515	0.000667	CcSEcCtD
Isotretinoin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.000667	CcSEcCtD
Isotretinoin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000515	0.000667	CcSEcCtD
Isotretinoin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.000666	CcSEcCtD
Isotretinoin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.000661	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000509	0.000659	CcSEcCtD
Isotretinoin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000509	0.000659	CcSEcCtD
Isotretinoin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.000657	CcSEcCtD
Isotretinoin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.000655	CcSEcCtD
Isotretinoin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000505	0.000653	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000504	0.000653	CcSEcCtD
Isotretinoin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.000652	CcSEcCtD
Isotretinoin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.000649	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.000649	CcSEcCtD
Isotretinoin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.000648	CcSEcCtD
Isotretinoin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000499	0.000646	CcSEcCtD
Isotretinoin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000499	0.000646	CcSEcCtD
Isotretinoin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000497	0.000644	CcSEcCtD
Isotretinoin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.000643	CcSEcCtD
Isotretinoin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000496	0.000643	CcSEcCtD
Isotretinoin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.000642	CcSEcCtD
Isotretinoin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00064	CcSEcCtD
Isotretinoin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00064	CcSEcCtD
Isotretinoin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.000639	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000493	0.000638	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000493	0.000638	CcSEcCtD
Isotretinoin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000637	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.000636	CcSEcCtD
Isotretinoin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.000635	CcSEcCtD
Isotretinoin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00063	CcSEcCtD
Isotretinoin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00063	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000483	0.000625	CcSEcCtD
Isotretinoin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000624	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000624	CcSEcCtD
Isotretinoin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00062	CcSEcCtD
Isotretinoin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00062	CcSEcCtD
Isotretinoin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.000617	CcSEcCtD
Isotretinoin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.000617	CcSEcCtD
Isotretinoin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000476	0.000617	CcSEcCtD
Isotretinoin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000476	0.000617	CcSEcCtD
Isotretinoin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000615	CcSEcCtD
Isotretinoin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.000614	CcSEcCtD
Isotretinoin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00061	CcSEcCtD
Isotretinoin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.000609	CcSEcCtD
Isotretinoin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.000609	CcSEcCtD
Isotretinoin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.000609	CcSEcCtD
Isotretinoin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000469	0.000607	CcSEcCtD
Isotretinoin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.000607	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000469	0.00252	CbGpPWpGaD
Isotretinoin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.000605	CcSEcCtD
Isotretinoin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000467	0.000604	CcSEcCtD
Isotretinoin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000467	0.000604	CcSEcCtD
Isotretinoin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000466	0.000603	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.000602	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000463	0.00249	CbGpPWpGaD
Isotretinoin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000462	0.000598	CcSEcCtD
Isotretinoin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000596	CcSEcCtD
Isotretinoin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.000595	CcSEcCtD
Isotretinoin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000459	0.000594	CcSEcCtD
Isotretinoin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000592	CcSEcCtD
Isotretinoin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.000585	CcSEcCtD
Isotretinoin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.000582	CcSEcCtD
Isotretinoin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.000582	CcSEcCtD
Isotretinoin—RXRG—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.00045	0.00242	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000449	0.00241	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000444	0.00239	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.000575	CcSEcCtD
Isotretinoin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000444	0.000575	CcSEcCtD
Isotretinoin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.000574	CcSEcCtD
Isotretinoin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000443	0.000573	CcSEcCtD
Isotretinoin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000442	0.000572	CcSEcCtD
Isotretinoin—RXRA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000437	0.00235	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000435	0.000563	CcSEcCtD
Isotretinoin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00056	CcSEcCtD
Isotretinoin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00056	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.00043	0.00231	CbGpPWpGaD
Isotretinoin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.000552	CcSEcCtD
Isotretinoin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000426	0.000552	CcSEcCtD
Isotretinoin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000423	0.000548	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000423	0.00227	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000422	0.00227	CbGpPWpGaD
Isotretinoin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000543	CcSEcCtD
Isotretinoin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.000543	CcSEcCtD
Isotretinoin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00054	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000415	0.00223	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000412	0.00222	CbGpPWpGaD
Isotretinoin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.000534	CcSEcCtD
Isotretinoin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000412	0.000534	CcSEcCtD
Isotretinoin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.000531	CcSEcCtD
Isotretinoin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000409	0.000529	CcSEcCtD
Isotretinoin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.000528	CcSEcCtD
Isotretinoin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000526	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000404	0.00217	CbGpPWpGaD
Isotretinoin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000404	0.000523	CcSEcCtD
Isotretinoin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.000521	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000402	0.00216	CbGpPWpGaD
Isotretinoin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.000518	CcSEcCtD
Isotretinoin—RARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000398	0.00214	CbGpPWpGaD
Isotretinoin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000398	0.000516	CcSEcCtD
Isotretinoin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.000516	CcSEcCtD
Isotretinoin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00039	0.000505	CcSEcCtD
Isotretinoin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000505	CcSEcCtD
Isotretinoin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.000504	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000385	0.00207	CbGpPWpGaD
Isotretinoin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000383	0.000496	CcSEcCtD
Isotretinoin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.000496	CcSEcCtD
Isotretinoin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.000492	CcSEcCtD
Isotretinoin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00038	0.000492	CcSEcCtD
Isotretinoin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.000491	CcSEcCtD
Isotretinoin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00038	0.000491	CcSEcCtD
Isotretinoin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000379	0.000491	CcSEcCtD
Isotretinoin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.000489	CcSEcCtD
Isotretinoin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000377	0.000489	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000377	0.00203	CbGpPWpGaD
Isotretinoin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000488	CcSEcCtD
Isotretinoin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000488	CcSEcCtD
Isotretinoin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.000487	CcSEcCtD
Isotretinoin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000375	0.000486	CcSEcCtD
Isotretinoin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000372	0.000482	CcSEcCtD
Isotretinoin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000372	0.000481	CcSEcCtD
Isotretinoin—RARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000371	0.002	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00048	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000371	0.00199	CbGpPWpGaD
Isotretinoin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00048	CcSEcCtD
Isotretinoin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00037	0.000479	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000366	0.000474	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000364	0.00196	CbGpPWpGaD
Isotretinoin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000472	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000472	CcSEcCtD
Isotretinoin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.000468	CcSEcCtD
Isotretinoin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.000467	CcSEcCtD
Isotretinoin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.000464	CcSEcCtD
Isotretinoin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.000464	CcSEcCtD
Isotretinoin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.000464	CcSEcCtD
Isotretinoin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.000463	CcSEcCtD
Isotretinoin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.000463	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000357	0.00192	CbGpPWpGaD
Isotretinoin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.000461	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000354	0.0019	CbGpPWpGaD
Isotretinoin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000455	CcSEcCtD
Isotretinoin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000351	0.000454	CcSEcCtD
Isotretinoin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.000448	CcSEcCtD
Isotretinoin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000447	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000345	0.00185	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000343	0.00184	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000343	0.00184	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.00034	0.00183	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000339	0.00182	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000338	0.00182	CbGpPWpGaD
Isotretinoin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000437	CcSEcCtD
Isotretinoin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.000435	CcSEcCtD
Isotretinoin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000434	CcSEcCtD
Isotretinoin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000432	CcSEcCtD
Isotretinoin—RARB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000333	0.00179	CbGpPWpGaD
Isotretinoin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00043	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000327	0.00176	CbGpPWpGaD
Isotretinoin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000422	CcSEcCtD
Isotretinoin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000422	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000324	0.00174	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000324	0.00174	CbGpPWpGaD
Isotretinoin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000416	CcSEcCtD
Isotretinoin—RARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000319	0.00172	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000319	0.00172	CbGpPWpGaD
Isotretinoin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000412	CcSEcCtD
Isotretinoin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.000408	CcSEcCtD
Isotretinoin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000404	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000312	0.00168	CbGpPWpGaD
Isotretinoin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000401	CcSEcCtD
Isotretinoin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000303	0.000392	CcSEcCtD
Isotretinoin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000386	CcSEcCtD
Isotretinoin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.000382	CcSEcCtD
Isotretinoin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000382	CcSEcCtD
Isotretinoin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.000379	CcSEcCtD
Isotretinoin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000378	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000292	0.00157	CbGpPWpGaD
Isotretinoin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000376	CcSEcCtD
Isotretinoin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000376	CcSEcCtD
Isotretinoin—RXRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00029	0.00156	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000287	0.00154	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GC—chronic obstructive pulmonary disease	0.000282	0.00151	CbGpPWpGaD
Isotretinoin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.000361	CcSEcCtD
Isotretinoin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000354	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000273	0.00147	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000349	CcSEcCtD
Isotretinoin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000348	CcSEcCtD
Isotretinoin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000348	CcSEcCtD
Isotretinoin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000346	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000266	0.00143	CbGpPWpGaD
Isotretinoin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000339	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000262	0.00141	CbGpPWpGaD
Isotretinoin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000337	CcSEcCtD
Isotretinoin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.000336	CcSEcCtD
Isotretinoin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000331	CcSEcCtD
Isotretinoin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000326	CcSEcCtD
Isotretinoin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000325	CcSEcCtD
Isotretinoin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00032	CcSEcCtD
Isotretinoin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00032	CcSEcCtD
Isotretinoin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000319	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000318	CcSEcCtD
Isotretinoin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000316	CcSEcCtD
Isotretinoin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000311	CcSEcCtD
Isotretinoin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000307	CcSEcCtD
Isotretinoin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000307	CcSEcCtD
Isotretinoin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000305	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000234	0.00126	CbGpPWpGaD
Isotretinoin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000302	CcSEcCtD
Isotretinoin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000301	CcSEcCtD
Isotretinoin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000231	0.0003	CcSEcCtD
Isotretinoin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000298	CcSEcCtD
Isotretinoin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000297	CcSEcCtD
Isotretinoin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000293	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000225	0.00121	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.00022	0.00118	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00028	CcSEcCtD
Isotretinoin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000279	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000215	0.00116	CbGpPWpGaD
Isotretinoin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000278	CcSEcCtD
Isotretinoin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000276	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000211	0.00113	CbGpPWpGaD
Isotretinoin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00027	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00112	CbGpPWpGaD
Isotretinoin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000267	CcSEcCtD
Isotretinoin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000266	CcSEcCtD
Isotretinoin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000266	CcSEcCtD
Isotretinoin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000265	CcSEcCtD
Isotretinoin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000265	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000203	0.00109	CbGpPWpGaD
Isotretinoin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000262	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000201	0.00108	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000253	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000251	CcSEcCtD
Isotretinoin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000251	CcSEcCtD
Isotretinoin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000244	CcSEcCtD
Isotretinoin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000243	CcSEcCtD
Isotretinoin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000243	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000182	0.000976	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000179	0.00096	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000177	0.000951	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000226	CcSEcCtD
Isotretinoin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00022	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000169	0.000909	CbGpPWpGaD
Isotretinoin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000217	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000166	0.000894	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000166	0.000893	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.000876	CbGpPWpGaD
Isotretinoin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00021	CcSEcCtD
Isotretinoin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000203	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000156	0.00084	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000156	0.00084	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000154	0.000827	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000152	0.000818	CbGpPWpGaD
Isotretinoin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000195	CcSEcCtD
Isotretinoin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000194	CcSEcCtD
Isotretinoin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000193	CcSEcCtD
Isotretinoin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000192	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000142	0.000763	CbGpPWpGaD
Isotretinoin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000182	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000139	0.000746	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000135	0.000725	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.000688	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000122	0.000655	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000109	0.000588	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000107	0.000573	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000105	0.000566	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.0001	0.00054	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.85e-05	0.00053	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.8e-05	0.000527	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.38e-05	0.000504	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.3e-05	0.0005	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.14e-05	0.000438	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.57e-05	0.000407	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALB—chronic obstructive pulmonary disease	6.32e-05	0.00034	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NOS3—chronic obstructive pulmonary disease	6.04e-05	0.000325	CbGpPWpGaD
